We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+9.66%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$89.3B
AUM Growth
+$8.23B
(+10%)
Cap. Flow
+$1.9B
Cap. Flow
% of AUM
2.12%
Top 10 Holdings %
Top 10 Hldgs %
24.87%
Holding
4,460
New
1,490
Increased
1,679
Reduced
1,235
Closed
38
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$60.1M |
| 2 |
TSMC
TSM
|
+$59.1M |
| 3 |
Tesla
TSLA
|
+$56M |
| 4 |
Apple
AAPL
|
+$55.2M |
| 5 |
Amazon
AMZN
|
+$47.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI ACWI ex US ETF
ACWX
|
+$102M |
| 2 |
Everest Group
EG
|
+$27.4M |
| 3 |
Chevron
CVX
|
+$25M |
| 4 |
Wells Fargo
WFC
|
+$24.9M |
| 5 |
Crane NXT
CXT
|
+$13.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.27% |
| 2 | Healthcare | 12.98% |
| 3 | Financials | 12.17% |
| 4 | Consumer Discretionary | 11.18% |
| 5 | Industrials | 9.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2726
ACNB Corp
ACNB
$655M
| $410K | ﹤0.01% |
12,348
-115
| -0.9% | -$3.57K |
|
2727
ImmunityBio
IBRX
$8.1B
| $409K | ﹤0.01% |
147,145
+35,371
| +32% | +$100K |
|
2728
Civista Bancshares
CIVB
$589M
| $409K | ﹤0.01% |
23,480
-515
| -2% | -$8.2K |
|
|
MOND
2729
DELISTED
Mondee Holdings, Inc. Class A Common Stock
MOND
| $408K | ﹤0.01% |
+45,807
| New | +$466K |
|
|
ALPN
2730
DELISTED
Alpine Immune Sciences Inc
ALPN
| $405K | ﹤0.01% |
39,426
+6,578
| +20% | +$59.3K |
|
|
ICPT
2731
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $405K | ﹤0.01% |
36,619
+2,436
| +7% | +$33.9K |
|
2732
SGHC Ltd
SGHC
$6.63B
| $404K | ﹤0.01% |
+139,206
| New | +$492K |
|
2733
New Oriental
EDU
$8.98B
| $403K | ﹤0.01% |
+10,213
| New | +$409K |
|
2734
Oric Pharmaceuticals
ORIC
$1.4B
| $403K | ﹤0.01% |
+51,905
| New | +$295K |
|
2735
MediaAlpha
MAX
$821M
| $401K | ﹤0.01% |
38,870
+6,047
| +18% | +$54.7K |
|
2736
Financial Institutions
FISI
$821M
| $400K | ﹤0.01% |
25,405
-12,316
| -33% | -$208K |
|
2737
Five Star Bancorp
FSBC
$1.13B
| $400K | ﹤0.01% |
17,871
-301
| -2% | -$6.11K |
|
2738
Accuray
ARAY
$34M
| $400K | ﹤0.01% |
103,281
+91,843
| +803% | +$318K |
|
2739
Tenaya Therapeutics
TNYA
$163M
| $399K | ﹤0.01% |
68,010
+3,038
| +5% | +$17.7K |
|
2740
iShares US Treasury Bond ETF
GOVT
$43.6B
| $399K | ﹤0.01% |
17,410
| – | – |
|
2741
EverCommerce
EVCM
$1.93B
| $397K | ﹤0.01% |
33,533
-1,529
| -4% | -$17.9K |
|
|
BLFY
2742
DELISTED
Blue Foundry Bancorp
BLFY
| $396K | ﹤0.01% |
39,195
-1,301
| -3% | -$12.5K |
|
|
FLIC
2743
DELISTED
First of Long Island Corp
FLIC
| $396K | ﹤0.01% |
32,957
-1,710
| -5% | -$19.9K |
|
2744
NerdWallet
NRDS
$652M
| $396K | ﹤0.01% |
42,091
+7,545
| +22% | +$85.2K |
|
2745
Cosan
CSAN
$2.84B
| $395K | ﹤0.01% |
+26,477
| New | +$344K |
|
|
NVTA
2746
DELISTED
Invitae Corporation
NVTA
| $394K | ﹤0.01% |
348,642
-42,196
| -11% | -$53.2K |
|
|
GBIO
2747
DELISTED
Generation Bio
GBIO
| $393K | ﹤0.01% |
7,143
-348
| -5% | -$16K |
|
|
ENFN
2748
DELISTED
Enfusion, Inc.
ENFN
| $393K | ﹤0.01% |
35,007
+1,098
| +3% | +$9.73K |
|
2749
Build-A-Bear
BBW
$462M
| $392K | ﹤0.01% |
18,307
-2,301
| -11% | -$50.3K |
|
|
PTRA
2750
DELISTED
Proterra Inc. Common Stock
PTRA
| $392K | ﹤0.01% |
326,644
+11,626
| +4% | +$14.3K |
|
Similar funds
VAM
RhumbLine Advisers's Q2 2023 Portfolio in Review
As of Q2 2023, RhumbLine Advisers held 4,460 positions worth $89.3B, up 10% from $81B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
RhumbLine Advisers's Q2 2023 filing shows 1,490 new, 1,679 increased, 1,235 reduced and 38 closed positions. Its largest new stake was TSMC: 635,517 shares worth $64.1M. The largest sale was iShares MSCI ACWI ex US ETF, an estimated $102M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Healthcare and Financials.
- RhumbLine Advisers's largest Q2 2023 buy was TSMC: 635,517 shares worth $64.1M.
- RhumbLine Advisers added most to Microsoft in Q2 2023, an estimated $60.1M increase.
- RhumbLine Advisers's biggest Q2 2023 reduction was iShares MSCI ACWI ex US ETF, cutting an estimated $102M.
- RhumbLine Advisers fully exited Everest Group in Q2 2023, selling an estimated $27.4M.
- RhumbLine Advisers's ten largest holdings make up 25% of its $89.3B portfolio in Q2 2023.
- RhumbLine Advisers opened 1,490 new positions and closed 38 in Q2 2023.
- RhumbLine Advisers's portfolio value rose 10% quarter-over-quarter to $89.3B.
Based on RhumbLine Advisers's 13F filing for Q2 2023, filed 8 Aug 2023.